Disc Medicine (IRON) PT Lowered to $50 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman lowered the price target on Disc Medicine (NASDAQ: IRON) to $50.00 (from $80.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
